With the Directorial Decree of August 4, 2021, the Ministry of Health amended Annex 1 of the Ministerial Decree of August 10, 2018 containing the list of admitted plants and related parts. Garcinia Cambogia is admissible on the market only with the following wording on the label “IMPORTANT WARNING If, following the use of the product, disturbances arise, eg. of liver function or central nervous system, stop taking it and seek the advice of the doctor “. The guidelines for physiological effects (Lipid metabolism. Body weight balance. Control of the sense of hunger) have been removed so these claims can no longer be used on labels or in advertising. Food business operators responsible for placing food supplements containing Garcinia Cambogia on the market must adapt to the new provisions no later than 31/12/2021.